A carregar...

Pharmacogenetics and Clopidogrel Response in Patients Undergoing Percutaneous Coronary Interventions

A 62-year-old presents with angina. He has been genotyped for a panel of drug metabolism enzymes through a direct-to-consumer genetics company. His results reveal a CYP2C19 *2/*2 genotype with a warning that poor metabolizers (PMs) may have “lack of therapeutic effect of clopidogrel (Plavix), result...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Beitelshees, AL, Horenstein, RB, Vesely, MR, Mehra, MR, Shuldiner, AR
Formato: Artigo
Idioma:Inglês
Publicado em: 2011
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3235907/
https://ncbi.nlm.nih.gov/pubmed/21270785
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/clpt.2010.316
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!